Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Oct 25, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aprea Therapeutics, Inc.
| -6.46K |
$4.58 | -$29,583.04 | -2.69% | 233.65K |
Oct 18
| |||||||
Aprea Therapeutics, Inc.
| 500 |
$3.92 | $1,957.50 | +0.15% | 333.39K |
Oct 23
| |||||||
Aprea Therapeutics, Inc.
| 30K |
$4.39 | $131,700.00 | +14.28% | 240.11K |
Oct 16
| |||||||
Aprea Therapeutics, Inc.
| 250 |
$2.90 | $725.00 | +0.08% | 332.89K |
Oct 15
| |||||||
Aprea Therapeutics, Inc.
| 190 |
$2.58 | $490.20 | +0.09% | 210.11K |
Oct 14
| |||||||
Aprea Therapeutics, Inc.
| 50 |
$2.46 | $123.19 | +0.26% | 19.37K |
Oct 11
| |||||||
Aprea Therapeutics, Inc.
| 10K |
$2.68 | $26,800.00 | +28.79% | 44.73K |
Oct 11
| |||||||
Aprea Therapeutics, Inc.
| 1.15K |
$2.58 | $2,971.00 | +0.35% | 332.64K |
Oct 10 - Oct 14
| |||||||
Aprea Therapeutics, Inc.
| 450 |
$2.61 | $1,174.50 | +2.38% | 19.32K |
Oct 10
| |||||||
Aprea Therapeutics, Inc.
| 1.04K |
—
|
—
| +3.10% | 34.73K |
Jun 20
| |||||||
Aprea Therapeutics, Inc.
| 1.04K |
—
|
—
| +31.14% | 4.4K |
Jun 20
| |||||||
Aprea Therapeutics, Inc.
| 1.04K |
—
|
—
| +101.55% | 2.07K |
Jun 20
| |||||||
Aprea Therapeutics, Inc.
| 1.04K |
—
|
—
| +12.84% | 9.18K |
Jun 20
| |||||||
Aprea Therapeutics, Inc.
| 1.04K |
—
|
—
| +130.79% | 1.84K |
Jun 20
| |||||||
Aprea Therapeutics, Inc.
| 1.04K |
—
|
—
| +0.50% | 209.92K |
Jun 20
| |||||||
Aprea Therapeutics, Inc.
| 6.73K |
—
|
—
|
∞
| 6.73K |
May 1
| |||||||
Aprea Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Aprea Therapeutics, Inc.
| 3.37K |
—
|
—
| +21.71% | 18.87K |
Mar 28
| |||||||
Aprea Therapeutics, Inc.
| 6.72K |
—
|
—
| +2.07% | 331.5K | +1 |
Mar 28
| ||||||
Aprea Therapeutics, Inc.
| 1.01K |
$7.29 | $7,362.90 | +6.97% | 15.5K |
Mar 13
| |||||||
Aprea Therapeutics, Inc.
| 6.86K |
$7.29 | $50,009.40 | +25.57% | 33.69K |
Mar 13
| |||||||
Aprea Therapeutics, Inc.
| 6.86K |
$7.29 | $50,009.40 | +536.36% | 8.14K |
Mar 13
| |||||||
Aprea Therapeutics, Inc.
| 2K |
$7.29 | $14,580.00 | +0.62% | 324.77K | +1 |
Mar 13
| ||||||
Aprea Therapeutics, Inc.
| 321.65K |
—
|
—
|
∞
| 74.61K |
Aug 23 - Aug 23
| |||||||
Aprea Therapeutics, Inc.
| 500 |
—
|
—
| +167.22% | 799 |
Aug 23
| |||||||
Aprea Therapeutics, Inc.
| 500 |
—
|
—
| +64.18% | 1.28K |
Aug 23
| |||||||
Aprea Therapeutics, Inc.
| 500 |
—
|
—
| +94.52% | 1.03K |
Aug 23
| |||||||
Aprea Therapeutics, Inc.
| 4.02M |
—
|
—
| +1,132.04% | 4.38M |
Aug 23 - Aug 23
| |||||||
Aprea Therapeutics, Inc.
| 500 |
—
|
—
| +1.90% | 26.82K |
Aug 23
| |||||||
Aprea Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Aug 23
| |||||||
Aprea Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Aprea Therapeutics, Inc.
| 10.1K |
$3.66 | $36,956.55 | +62.22% | 26.32K |
Jun 6 - Jun 7
| |||||||
Aprea Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 5
| |||||||
Aprea Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Aprea Therapeutics, Inc.
| 6.05M |
—
|
—
| +931.94% | 6.7M | +1 |
Aug 23 - Mar 9
| ||||||
Aprea Therapeutics, Inc.
| 1K |
$5.25 | $5,250.00 | +7.41% | 14.49K |
Feb 27
| |||||||
Aprea Therapeutics, Inc.
| 269.88K |
—
|
—
|
∞
| 269.88K |
Jan 30
| |||||||
Aprea Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Aprea Therapeutics, Inc.
| 6K |
—
|
—
| +1.88% | 324.57K |
Jul 28
| |||||||
Aprea Therapeutics, Inc.
| 32.4K |
—
|
—
| +14.28% | 259.25K |
Jul 28
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.